Cibc Private Wealth Group, LLC Regeneron Pharmaceuticals, Inc. Transaction History

Cibc Private Wealth Group, LLC

  • $51.3 Billion
  • Q1 2025

A detailed history of Cibc Private Wealth Group, LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Cibc Private Wealth Group, LLC holds 1,996 shares of REGN stock, worth $1.28 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,996
Previous 2,116 5.67%
Holding current value
$1.28 Million
Previous $1.51 Million 16.06%
% of portfolio
0.0%
Previous 0.0%

Shares

35 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 14, 2025
SELL
$634.14 - $744.83 $76,096 - $89,379
-120 Reduced 5.67%
1,996 $1.27 Million
Q4 2024

Feb 12, 2025
SELL
$701.85 - $1046.91 $306,006 - $456,452
-436 Reduced 17.08%
2,116 $1.51 Million
Q3 2024

Nov 13, 2024
BUY
$1024.09 - $1201.76 $319,516 - $374,949
312 Added 13.93%
2,552 $2.68 Million
Q2 2024

Aug 09, 2024
SELL
$883.2 - $1071.19 $62,707 - $76,054
-71 Reduced 3.07%
2,240 $2.35 Million
Q1 2024

May 10, 2024
SELL
$902.69 - $993.35 $58,674 - $64,567
-65 Reduced 2.74%
2,311 $2.22 Million
Q4 2023

Feb 13, 2024
BUY
$775.18 - $881.7 $2,325 - $2,645
3 Added 0.13%
2,376 $2.09 Million
Q3 2023

Nov 13, 2023
BUY
$692.45 - $844.37 $945,886 - $1.15 Million
1,366 Added 135.65%
2,373 $1.95 Million
Q2 2023

Nov 21, 2023
SELL
$700.03 - $830.35 $956,240 - $1.13 Million
-1,366 Reduced 57.56%
1,007 $723,000
Q2 2023

Aug 10, 2023
SELL
$700.03 - $830.35 $39,201 - $46,499
-56 Reduced 5.27%
1,007 $723,000
Q1 2023

Nov 21, 2023
SELL
$680.49 - $826.97 $891,441 - $1.08 Million
-1,310 Reduced 55.2%
1,063 $873,000
Q1 2023

May 11, 2023
SELL
$680.49 - $826.97 $476,343 - $578,879
-700 Reduced 39.71%
1,063 $873,000
Q4 2022

Jun 01, 2023
BUY
$705.89 - $766.39 $494,123 - $536,473
700 Added 65.85%
1,763 $1.27 Million
Q4 2022

Feb 13, 2023
SELL
$705.89 - $766.39 $5.75 Million - $6.25 Million
-8,150 Reduced 82.22%
1,763 $1.27 Million
Q3 2022

Nov 14, 2022
SELL
$573.97 - $724.32 $451,140 - $569,315
-786 Reduced 7.35%
9,913 $6.83 Million
Q2 2022

Aug 03, 2022
SELL
$548.35 - $738.84 $16,998 - $22,904
-31 Reduced 0.29%
10,699 $6.32 Million
Q1 2022

May 16, 2022
SELL
$595.12 - $698.43 $191,033 - $224,196
-321 Reduced 2.9%
10,730 $7.49 Million
Q4 2021

Feb 08, 2022
BUY
$543.48 - $670.97 $609,241 - $752,157
1,121 Added 11.29%
11,051 $6.98 Million
Q3 2021

Nov 12, 2021
SELL
$574.03 - $680.96 $400,098 - $474,629
-697 Reduced 6.56%
9,930 $6.01 Million
Q2 2021

Aug 16, 2021
SELL
$472.8 - $558.54 $95,032 - $112,266
-201 Reduced 1.86%
10,627 $5.94 Million
Q1 2021

May 12, 2021
SELL
$446.73 - $548.2 $5.27 Million - $6.47 Million
-11,798 Reduced 52.14%
10,828 $5.12 Million
Q4 2020

Feb 12, 2021
BUY
$478.3 - $607.98 $574,916 - $730,791
1,202 Added 5.61%
22,626 $10.9 Million
Q3 2020

Nov 03, 2020
BUY
$544.75 - $658.21 $10.9 Million - $13.1 Million
19,964 Added 1367.4%
21,424 $12.1 Million
Q3 2020

Oct 29, 2020
SELL
$544.75 - $658.21 $5.73 Million - $6.93 Million
-10,525 Reduced 87.82%
1,460 $817,000
Q2 2020

Aug 13, 2020
SELL
$493.32 - $643.92 $4.52 Million - $5.89 Million
-9,153 Reduced 43.3%
11,985 $7.47 Million
Q1 2020

May 15, 2020
BUY
$336.18 - $494.43 $870,706 - $1.28 Million
2,590 Added 13.96%
21,138 $10.3 Million
Q4 2019

Jan 30, 2020
BUY
$274.13 - $376.51 $167,493 - $230,047
611 Added 3.41%
18,548 $6.96 Million
Q3 2019

Oct 16, 2019
BUY
$273.46 - $318.39 $436,989 - $508,787
1,598 Added 9.78%
17,937 $4.97 Million
Q2 2019

Jul 31, 2019
SELL
$299.6 - $414.82 $228,594 - $316,507
-763 Reduced 4.46%
16,339 $5.11 Million
Q1 2019

May 10, 2019
BUY
$372.08 - $439.57 $4.35 Million - $5.14 Million
11,683 Added 215.59%
17,102 $7.02 Million
Q4 2018

Feb 05, 2019
SELL
$335.82 - $403.04 $473,170 - $567,883
-1,409 Reduced 20.64%
5,419 $2.02 Million
Q3 2018

Nov 14, 2018
BUY
$351.14 - $408.51 $480,008 - $558,433
1,367 Added 25.03%
6,828 $2.76 Million
Q2 2018

Aug 02, 2018
SELL
$284.6 - $344.99 $32,159 - $38,983
-113 Reduced 2.03%
5,461 $1.88 Million
Q1 2018

May 17, 2018
SELL
$315.82 - $393.78 $33,161 - $41,346
-105 Reduced 1.85%
5,574 $1.92 Million
Q4 2017

Feb 12, 2018
SELL
$358.63 - $469.95 $819,110 - $1.07 Million
-2,284 Reduced 28.68%
5,679 $2.14 Million
Q3 2017

Nov 14, 2017
BUY
$431.38 - $504.0 $3.44 Million - $4.01 Million
7,963
7,963 $3.56 Million

Others Institutions Holding REGN

# of Institutions
1,442
Shares Held
89M
Call Options Held
1.78M
Put Options Held
1.75M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $68.8B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Cibc Private Wealth Group, LLC Portfolio

Follow Cibc Private Wealth Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cibc Private Wealth Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cibc Private Wealth Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email